(Reuters) – Boston Scientific said on Wednesday the U.S. Food and Drug Administration has approved the company’s device for a type of heart condition.
(Reporting by Sriparna Roy in Bengaluru; Editing by Shounak Dasgupta)
(Reuters) – Boston Scientific said on Wednesday the U.S. Food and Drug Administration has approved the company’s device for a type of heart condition.
(Reporting by Sriparna Roy in Bengaluru; Editing by Shounak Dasgupta)

Comments